Nocardia spp. are rarely isolated in extrapulmonary clinical specimens. We describe the first case of olecranon bursitis caused by Nocardia asiatica. The patient, a traveler returning from Thailand, was successfully treated with linezolid.
ezolid. The MICs were read after 72 h of incubation at 35°C in ambient air and interpreted according the CLSI guidelines, although the Etest method is a non-CLSI-recommended method (2, 3, 4) . The MIC results are shown in Table 1 .
After susceptibility testing was available, the antimicrobial treatment was modified to oral trimethoprim-sulfamethoxazole (160 mg/800 mg) twice daily and amoxicillin-clavulanic acid was discontinued after a total of 4 days. Over the next 10 days, renal function constantly decreased and treatment was switched from trimethoprim-sulfamethoxazole to oral linezolid (600 mg) twice daily. Linezolid was chosen because it was the only available agent for oral outpatient treatment. After that, the renal function tests normalized. Because the pain persisted, a second operation was performed, revealing a glass splinter measuring 0.5 by 1.2 cm. After the splinter was removed, the pain disappeared, and antimicrobial treatment was discontinued after a total of 30 days (10 days of trimethoprim-sulfamethoxazole and 20 days of linezolid). To date, the patient has had no relapse.
The genus Nocardia is a member of the family Nocardiaceae belonging to the order Actinomycetales. More than 50 species of these environmental bacteria are described, which can be found in soil and other organic matter. Nocardia spp. are Gram-positive filamentous branching bacteria that grow aerobically, have a typical earthy odor, and show partial acid fastness when stained with modified Kinyoun stain (5, 6 ). Identification to the species level is challenging, although a battery of tests have been established, including resistance profiles and biochemical characteristics (7). Sequencing of the 16S rRNA gene has become a valuable tool for the identification of clinical isolates (6) . In this case, Nocardia asiatica was identified after 16S rRNA sequencing. Further phenotypic testing of the isolate was done as described by Kiska et al. and led to the following findings (7): susceptibility testing by disk diffusion with gentamicin, tobramycin, amikacin, and erythromycin led to the profile S-S-S-R (S, susceptible; R, resistant) for the respective drugs; for biochemical characteristics, the Coryne Api (bioMéri-eux) was applied, and the bio number obtained after 72 h of incubation at 35°C was 3042321; growth was detected at 35°C but not at 45°C; and the culture stayed chalky white after 5 days of incubation.
Nocardia spp. are in general described as opportunistic pathogens causing mainly pulmonary nocardiosis in immunocompromised patients. The most-common extrapulmonary location of infections is the central nervous system. Skin and soft tissue nocardiosis can result from traumatic injury to the skin involving contamination with soil (5, 8) . This is the second case of a Nocardia bursitis but the first case with Nocardia asiatica identified as the infectious agent. In 1988, Chowdhary et al. described the first case, which was an olecranon bursitis caused by Nocardia asteriodes in an immunocompetent patient (9) . Nocardia asiatica was first described by Kageyama et al., who reported five cases, three from Thailand and two from Japan (1). We report for the first time Nocardia asiatica as a cause of olecranon bursitis in an immunocompetent patient. Furthermore, this is only the third report of the isolation of Nocardia asiatica in Europe, even if the source of infection was Thailand. The first European case was reported from Italy in 2007, describing an isolate from a cutaneous ulcer in an immunocompromised gardener; the second, from Belgium, described a pulmonary nocardiosis in an asthmatic immunocompetent patient living in Belgium for 1.5 years and originating from Colombia (10, 11) . Furthermore, there is a case from Lebanon describing an infection with Nocardia asiatica presenting as an anterior mediastinal mass in a patient with myasthenia gravis and a history of medical treatment in Iraq and India (12) .
In this case, empirical antimicrobial therapy with amoxicillinclavulanic acid failed. Antimicrobial susceptibility testing showed resistance to this agent, as well as to quinolones and to macrolides, which seems to be a characteristic profile for Nocardia asiatica as recently reported (2, 11, 13) . For the treatment of nocardiosis, trimethoprim-sulfamethoxazole is the most commonly used antimicrobial agent (5, 8, 13) . Due to renal complications, therapy was successfully switched to linezolid, as described previously (14) . This is the first report of an olecranon bursitis in an immunocompetent patient caused by Nocardia asiatica. This case highlights that clinicians should consider atypical agents in travelers and the importance of microbiological diagnostic procedures.
Nucleotide sequence accession number. The 16S rRNA gene sequence of the isolate was deposited in GenBank under accession number KC333452. 
